Psychotherapy of schizophrenia: Not a problem of evidence, but a problem of implementation;Psychotherapie bei schizophrenen störungen: Kein evidenz-, sondern ein implementierungsproblem

Psychiatrische Praxis

Volumn 41, Issue 1, 2014, Pages 8-10

  Bechdolf, Andreas ^a,b,c   Klingberg, Stefan ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA;

COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; EARLY MEDICAL INTERVENTION; EVIDENCE-BASED MEDICINE; FAMILY THERAPY; GERMANY; GUIDELINE ADHERENCE; HEALTH SERVICES ACCESSIBILITY; HUMANS; NATIONAL HEALTH PROGRAMS; PSYCHOTHERAPY; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84892507743     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0033-1359957     Document Type: Review

References (27)

1. Murray C. J., Lopez A. D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet: 1997; 349 1436 1442
2. Hor K., Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol: 2010; 24 04 81 90
3. Mueser K. T., Salyers M. P., Mueser P. R. A prospective analysis of work in schizophrenia. Schizophr Bull: 2001; 27 281 296
4. Lieberman J. A., Stroup T. S., McEvoy J. P. et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med: 2005; 353 1209 1223
5. Keefe R. Cognitive deficits in patients with schizophrenia: effects and treatment. J Clin Psychiatry: 2006; 68 8 13
6. Robinson D., Woerner M. G., Alvir J. M. et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiat: 1999; 56 241 247
7. Rüsch N., Berger M., Finzen A., Angermeyer M. Das Stigma psychischer Erkrankungen - Ursachen, Formen und therapeutische Konsequenzen. In: Berger M. Hrsg. Psychische Erkrankungen: Klinik und Therapie. 3. Auflage. München Urban & Fischer: 2009; 1091 1100
8. Bäuml J., Froböse T., Kraemer S. et al. Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophr Bull: 2006; 32 01 S1 S9
9. Bechdolf A., Knost B., Kuntermann C. et al. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr Scand: 2004; 110 21 28
10. Bechdolf A., Köhn D., Knost B. et al. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatr Scand: 2005; 112 173 179
11. Buchkremer G., Klingberg S., Holle R. et al. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up. Acta Psychiatr Scand: 1997; 96 483 491
12. Klingberg S., Wittorf A., Meisner C. et al. Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: The POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial. Trials: 2010; 11 123
13. Wykes T., Steel C., Everitt B. et al. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull: 2008; 34 523 537
14. Driessen E., Hollon S. D. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am: 2010; 33 537 555
15. Pharoah F., Mari J., Rathbone J. et al. Family intervention for schizophrenia. Cochrane Database Syst Rev: 2010; 12 CD000088
16. Psaty B. M., Lumley T., Furberg C. D. et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. JAMA: 2003; 289 2534 2544
17. McGurk S. R., Twamley E. W., Sitzer D. I. et al. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry: 2007; 164 1791 1802
18. Xia J., Merinder L. B., Belgamwar M. R. Psychoeducation for schizophrenia. Cochrane Database Syst Rev: 2011; 06 CD002831
19. van der Gaag M., Smit F., Bechdolf A. et al. Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res: 2013; 149 56 62
20. National Institute for Health and Clinical Excellence Schizophrenia NICE clinical guideline 82. Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). Im Internet: http://publications.nice.org.uk/schizophrenia-cg82 (Stand: 27.11.2013)
21. Dixon L. B., Dickerson F., Bellack A. S. et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull: 2010; 36 48 70
22. Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) S3 Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1 - Behandlungsleitlinie Schizophrenie Darmstadt Steinkopff-Verlag: 2005
23. Görgen W., Engler U. Ambulante psychotherapeutische Versorgung von psychosekranken Menschen sowie älteren Menschen in Berlin. Heidelberg Verlagsgruppe Hüthig Jehle Rehm: 2005
24. Wittmann W. W., Lutz W., Steffanowski A. et al. Qualitätsmonitoring in der ambulanten Psychotherapie: Modellprojekt der Techniker Krankenkasse - Abschlussbericht. Hamburg Techniker Krankenkasse: 2011
25. Rummel-Kluge C., Pitschel-Walz G., Bäuml J. et al. Psychoeducation in schizophrenia - results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull: 2006; 32 765 775
26. Kemp R., Hayward P., Applewhaite G. et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ: 1996; 312 345 349
27. Kemp R., Kirov G., Everitt B. et al. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry: 1998; 172 413 419